BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8051581)

  • 1. Rheumatoid arthritis: a complication of interferon therapy.
    Nadir F; Fagiuoli S; Wright HI; Nadir A; Hopp E; Gavaler J; Van Thiel DH
    J Okla State Med Assoc; 1994 May; 87(5):228-30. PubMed ID: 8051581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arthritis in a patient with psoriasis after interferon-alpha therapy for chronic hepatitis C.
    Makino Y; Tanaka H; Nakamura K; Fujita M; Akiyama K; Makino I
    J Rheumatol; 1994 Sep; 21(9):1771-2. PubMed ID: 7799367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant interferon-alpha therapy and tumor necrosis factor alpha inhibition for rheumatoid arthritis and hepatitis C.
    Niewold TB; Gibofsky A
    Arthritis Rheum; 2006 Jul; 54(7):2335-7. PubMed ID: 16802375
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic paranoid psychosis and dementia following interferon-alpha treatment of hepatitis C: a case report.
    Drozdz W; Borkowska A; Wilkosc M; Halota W; Dybowska D; Rybakowski JK
    Pharmacopsychiatry; 2007 Jul; 40(4):146-8. PubMed ID: 17694476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review.
    Boonyapisit K; Katirji B
    Muscle Nerve; 2002 Jun; 25(6):909-13. PubMed ID: 12115983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3 cases of polyarthritis treated with recombinant alfa interferon].
    Chazerain P; Meyer O; Ribard P; De Bandt M; Mechelany C; Marcellin P; Bernard JF; Grossin M; Kahn MF
    Rev Rhum Mal Osteoartic; 1992 May; 59(5):303-9. PubMed ID: 1411190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis.
    Georgetson MJ; Yarze JC; Lalos AT; Webster GF; Martin P
    Am J Gastroenterol; 1993 Oct; 88(10):1756-8. PubMed ID: 8213720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C.
    Pittau E; Bogliolo A; Tinti A; Mela Q; Ibba G; Salis G; Perpignano G
    Clin Exp Rheumatol; 1997; 15(4):415-9. PubMed ID: 9272304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha associated arthritis.
    Chung A; Older SA
    J Rheumatol; 1997 Sep; 24(9):1844-5. PubMed ID: 9292816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection.
    Wilson LE; Widman D; Dikman SH; Gorevic PD
    Semin Arthritis Rheum; 2002 Dec; 32(3):163-73. PubMed ID: 12528081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant interferon therapy and rheumatoid arthritis--a contraindication?
    Tsianakas A; Schiller M; Luger TA; Sunderkoetter C
    Acta Oncol; 2009; 48(3):468-9. PubMed ID: 18759142
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mono-arthritis following intensified interferon beta therapy for chronic hepatitis C.
    Murata K; Shiraki K; Takase K; Nakano T; Tameda Y
    Hepatogastroenterology; 2002; 49(47):1418-9. PubMed ID: 12239955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C.
    Fujii H; Kitada T; Yamada T; Sakaguchi H; Seki S; Hino M
    Hepatogastroenterology; 2003; 50(51):841-2. PubMed ID: 12828100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus-related arthritis.
    Palazzi C; D'Angelo S; Olivieri I
    Autoimmun Rev; 2008 Oct; 8(1):48-51. PubMed ID: 18707027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-induced sarcoidosis.
    Doyle MK; Berggren R; Magnus JH
    J Clin Rheumatol; 2006 Oct; 12(5):241-8. PubMed ID: 17023810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
    Brillanti S; Foli M; Di Tomaso M; Gramantieri L; Masci C; Bolondi L
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):130-4. PubMed ID: 10363198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple extrahepatic manifestations in a patient with chronic hepatitis C treated with interferon-alfa].
    Napoli N; Tortorella C; Deramo MT; Antonaci A; Parisi CV; Antonaci S
    Recenti Prog Med; 2004 Nov; 95(11):525-8. PubMed ID: 15598090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.